Maine Hemophilia and Thrombosis Center
Scarborough, Maine, United States
Medical clinic in Scarborough, Maine
100 Campus Dr #107, Scarborough, ME 04074
About Maine Hemophilia and Thrombosis Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
American Thrombosis and Hemostasis Network
6
Bayer
1
Clinical Trials at Maine Hemophilia and Thrombosis Center
During the past decade, Maine Hemophilia and Thrombosis Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry
2018-08-06
2020-05-14
Terminated
3
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
2018-10-03
2022-12-31
Completed
237
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
2020-09-30
2035-12-01
Recruiting
3,000
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
2021-06-28
2025-06-01
Recruiting
55
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Hemophilia and Thrombosis Center"
#1 collaborator was "CSL Behring" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "American Thrombosis and Hemostasis Network" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "BioMarin Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Maine Hemophilia and Thrombosis Center
According to Clinical.Site data, the most researched conditions in "Maine Hemophilia and Thrombosis Center" are
"Hemophilia" (3 trials), "Hemophilia A With Inhibitor" (3 trials), "Hemophilia B With Inhibitor" (3 trials), "Haemophilia A Without Inhibitor" (2 trials) and "Haemophilia B Without Inhibitor" (2 trials). Many other conditions were trialed in "Maine Hemophilia and Thrombosis Center" in a lesser frequency.
Clinical Trials Intervention Types at Maine Hemophilia and Thrombosis Center
Most popular intervention types in "Maine Hemophilia and Thrombosis Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials), "Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials), "New FVIII products" (1 trials) and "coagulation factor VIIa [recombinant]-jncw" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Maine Hemophilia and Thrombosis Center
The vast majority of trials in "Maine Hemophilia and Thrombosis Center" are
7 trials for "All" genders.
Clinical Trials Status at Maine Hemophilia and Thrombosis Center
Currently, there are NaN active trials in "Maine Hemophilia and Thrombosis Center".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Maine Hemophilia and Thrombosis Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Maine Hemophilia and Thrombosis Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".